Phase I of the proposed project will examine barriers to comprehensive HIV and other infectious disease testing and follow-up care among substance abusers at a short term (detox) substance abuse treatment center. In Phase II an intervention that includes comprehensive testing, counseling, medical deferral, and practical strategies to overcome barriers to follow up care will be designed and pilot tested. During Phase III, the intervention will be evaluated against the standard of care of offering HIV testing done through a randomized controlled trial. Three hundred and forty-four participants will be randomized to receive either the comprehensive testing and facilitated referral intervention which will offer testing for HIV, hepatitis B and C, and the STDs gonorrhea and chlamydia (and trichomonas for women only) or standard of care HIV testing alone and referral for further hepatitis and STD testing. Primary endpoints will be the number of tests performed, the number of test results received, and the degree of follow up medical care obtained for the two groups.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23DA000460-03
Application #
6523131
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Comolli, Jean C
Project Start
2000-09-25
Project End
2005-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
3
Fiscal Year
2002
Total Cost
$134,912
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
039318308
City
Providence
State
RI
Country
United States
Zip Code
02906
Harro, Clayton D; Robertson, Michael N; Lally, Michelle A et al. (2009) Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults. AIDS Res Hum Retroviruses 25:103-14
Lally, Michelle A; Montstream-Quas, Sydney A; Tanaka, Sara et al. (2008) A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care STDS 22:53-64
Tedeschi, Sara K; Bonney, Loida E; Manalo, Rosario et al. (2007) Vaccination in juvenile correctional facilities: state practices, hepatitis B, and the impact on anticipated sexually transmitted infection vaccines. Public Health Rep 122:44-8
Lally, Michelle; Gaitanis, Melissa; Vallabhaneni, Snigdha et al. (2006) Willingness to receive an HIV vaccine among incarcerated persons. Prev Med 43:402-5
Lally, Michelle A; MacNevin, Ryan; Sergie, Ziad et al. (2005) A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center. AIDS Patient Care STDS 19:298-305
Lally, Michelle A; Alvarez, Sara; Macnevin, Ryan et al. (2002) Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment. Sex Transm Dis 29:752-5
Vining, E; Kosten, T R; Kleber, H D (1988) Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 83:567-75